Terms: = Endocrine gland cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Treatment
952 results:
1. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
Hoque MM; Iida Y; Kotani H; Harada M
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
[TBL] [Abstract] [Full Text] [Related]
2. Causal relationship of genetically predicted gut microbiota with thyroid cancer: a bidirectional two-sample mendelian randomization study.
Sun X; Chen S; Zhao S; Wang J; Cheng H
Front Endocrinol (Lausanne); 2024; 15():1284472. PubMed ID: 38495789
[TBL] [Abstract] [Full Text] [Related]
3. Static magnetic field reduces cisplatin resistance via increasing apoptosis pathways and genotoxicity in cancer cell lines.
Zafari J; Rastegar-Pouyani N; Javani Jouni F; Najjar N; Azarshin SZ; Jafarzadeh E; Abdolmaleki P; Hoseini Shirazi F
Sci Rep; 2024 Mar; 14(1):5792. PubMed ID: 38461218
[TBL] [Abstract] [Full Text] [Related]
4. Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts.
Arakawa Y; Jo U; Kumar S; Sun NY; Elloumi F; Thomas A; Roper N; Varghese DG; Takebe N; Zhang X; Ceribelli M; Holland DO; Beck E; Itkin Z; McKnight C; Wilson KM; Travers J; Klumpp-Thomas C; Thomas CJ; Hoang CD; Hernandez JM; Del Rivero J; Pommier Y
Cancer Res Commun; 2024 Mar; 4(3):834-848. PubMed ID: 38451783
[TBL] [Abstract] [Full Text] [Related]
5. Juglone-ascorbate treatment enhances reactive oxygen species mediated mitochondrial apoptosis in pancreatic cancer.
Erkoc-Kaya D; Arikoglu H; Guclu E; Dursunoglu D; Menevse E
Mol Biol Rep; 2024 Feb; 51(1):340. PubMed ID: 38393422
[TBL] [Abstract] [Full Text] [Related]
6. VNP20009-Abvec-Igκ-MIIP suppresses ovarian cancer progression by modulating Ras/MEK/ERK signaling pathway.
Wang Q; Tang Y; Dai A; Li T; Pei Y; Zhang Z; Hu X; Chen T; Chen Q
Appl Microbiol Biotechnol; 2024 Feb; 108(1):218. PubMed ID: 38372808
[TBL] [Abstract] [Full Text] [Related]
7. Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.
Dash S; Ueda T; Komuro A; Honda M; Sugisawa R; Okada H
Cell Death Dis; 2024 Feb; 15(2):131. PubMed ID: 38346958
[TBL] [Abstract] [Full Text] [Related]
8. The urolithin B nanomicellar delivery system as an efficient selective anticancer compound.
Albuthyab NOM; Hosseini H; Homayouni Tabrizi M; Kharaghani M; Saghravanian SS
Mol Biol Rep; 2024 Jan; 51(1):85. PubMed ID: 38183506
[TBL] [Abstract] [Full Text] [Related]
9. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
[TBL] [Abstract] [Full Text] [Related]
10. [Saikosaponin D regulates apoptosis and autophagy of pancreatic cancer Panc-1 cells via Akt/mTOR pathway].
Guan YH; Liu GM; Liu YS; Lan LB; Zheng R; Liu XB
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5278-5284. PubMed ID: 38114117
[TBL] [Abstract] [Full Text] [Related]
11. Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.
Dayton TL; Alcala N; Moonen L; den Hartigh L; Geurts V; Mangiante L; Lap L; Dost AFM; Beumer J; Levy S; van Leeuwaarde RS; Hackeng WM; Samsom K; Voegele C; Sexton-Oates A; Begthel H; Korving J; Hillen L; Brosens LAA; Lantuejoul S; Jaksani S; Kok NFM; Hartemink KJ; Klomp HM; Borel Rinkes IHM; Dingemans AM; Valk GD; Vriens MR; Buikhuisen W; van den Berg J; Tesselaar M; Derks J; Speel EJ; Foll M; Fernández-Cuesta L; Clevers H
Cancer Cell; 2023 Dec; 41(12):2083-2099.e9. PubMed ID: 38086335
[TBL] [Abstract] [Full Text] [Related]
12. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells.
Ravindran F; Mhatre A; Koroth J; Narayan S; Choudhary B
Life Sci; 2023 Dec; 334():122224. PubMed ID: 38084671
[TBL] [Abstract] [Full Text] [Related]
13. Lovastatin treatment Inducing Apoptosis in Human Pancreatic cancer Cells by Inhibiting Cholesterol Rafts in Plasma Membrane and Mitochondria.
Gyoten M; Luo Y; Fujiwara-Tani R; Mori S; Ogata R; Kishi S; Kuniyasu H
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069135
[TBL] [Abstract] [Full Text] [Related]
14. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
15. Targeted delivery of genistein for pancreatic cancer treatment using hyaluronic-coated cubosomes bioactivated with frankincense oil.
Sallam NG; Boraie NA; Sheta E; El-Habashy SE
Int J Pharm; 2024 Jan; 649():123637. PubMed ID: 38008234
[TBL] [Abstract] [Full Text] [Related]
16. Biodegradable nanocarrier of gemcitabine and tocopherol succinate synergistically ameliorates anti-proliferative response in MIA PaCa-2 cells.
Behera C; Kaur Sandha K; Banjare N; Kumar Shukla M; Mudassir Ali S; Singh M; Gupta PN
Int J Pharm; 2024 Jan; 649():123599. PubMed ID: 37992978
[TBL] [Abstract] [Full Text] [Related]
17. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
18. Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells.
Hong P; Wu M; Wei X; Xu X; Wu P; Gan L; Wu R; Jin J; Zhang K; Li D; Chen M; Wong W; Liu W; Zheng X
Bioorg Chem; 2024 Jan; 142():106937. PubMed ID: 37913583
[TBL] [Abstract] [Full Text] [Related]
19. Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma.
Mao J; Tang L; Fang L; Tian C; Zhu Z; Li Y
Sci Rep; 2023 Oct; 13(1):18492. PubMed ID: 37898675
[TBL] [Abstract] [Full Text] [Related]
20. Strong apoptotic response of testis tumor cells following cisplatin treatment.
Köberle B; Usanova S; Piee-Staffa A; Heinicke U; Clauss P; Brozovic A; Kaina B
Int Urol Nephrol; 2024 Mar; 56(3):1007-1017. PubMed ID: 37891379
[TBL] [Abstract] [Full Text] [Related]
[Next]